Hassan Mohammed Abushukair (Hassan M Abushukair, H Abushukair, Hassann Abushukair, Hassan Abushukair)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 24

Top Topics

Metastatic Renal Cell Carcinoma

Tyrosine Kinase

Gene Expression

Top Venues

Nature communications

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Mamoun Ahram, Bayan Abu Alragheb, Hassan Mohammed Abushukair, Randa Bawadi, Maysa Al Hussaini
MicroRNAs Associated with Androgen Receptor and Metastasis in Triple-Negative Breast Cancer. Cancers 16 (3) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Mamoun Ahram, Bayan Abu Alragheb, Hassan Mohammed Abushukair, Randa Bawadi, Maysa Al Hussaini
MicroRNAs Associated with Androgen Receptor and Metastasis in Triple-Negative Breast Cancer. Cancers 16 (3) (2024)
Jood Hashem, Lujain Alkhalaileh, Hassan Mohammed Abushukair, Mahmoud Husni Ayesh Haj Yousef
miRNA Profiles in Patients with Hematological Malignancy at Different Stages of the Disease: A Preliminary Study. Biomedicines 12 (8) (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Jood Hashem, Lujain Alkhalaileh, Hassan Mohammed Abushukair, Mahmoud Husni Ayesh Haj Yousef
miRNA Profiles in Patients with Hematological Malignancy at Different Stages of the Disease: A Preliminary Study. Biomedicines 12 (8) (2024)
Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Celebre Baranda, Weijing Sun, Stephen K Williamson, Yu-Chiao Chiu, Hatice Ulku Osmanbeyoglu, Rashna Madan, Hassan Mohammed Abushukair, Kelly Mulvaney, Andrew K Godwin, Azhar Saeed
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort. Nature communications 15 (1) (2024)
Maluki Radford, Hassan Mohammed Abushukair, Stijn Hentzen, Ludimila Cavalcante, Anwaar Saeed
Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era. Journal of immunotherapy and precision oncology 6 (3) (2023)
Sohaib M Al-Khatib, Obada E Ababneh, Hassan Mohammed Abushukair, Nour Abdo, Laith Naser Al-Eitan
The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study. PloS one 18 (7) (2023)
Hassan Mohammed Abushukair, Obada E Ababneh, Ayah Al-Bzour, Ibrahim Halil Sahin, Anwaar Saeed
Next generation immuno-oncology biomarkers in gastrointestinal cancer: what does the future hold? Expert review of molecular diagnostics (2023)
Yaman B Ahmed, Ayah N Al-Bzour, Obada E Ababneh, Hassan Mohammed Abushukair, Anwaar Saeed
Genomic and Transcriptomic Predictors of Response to Immune Checkpoint Inhibitors in Melanoma Patients: A Machine Learning Approach. Cancers 14 (22) (2022)
Alireza Tojjari, Hassan Mohammed Abushukair, Anwaar Saeed
The Crosstalk between Microbiome and Immunotherapeutics: Myth or Reality. Cancers 14 (19) (2022)
Wisam Algargaz, Hassan Mohammed Abushukair, Fareed Barakat, Issa Mohamad
Transcervical approach to oropharyngeal synovial sarcoma: a case report. Future science OA 8 (8) (2022)
Aviva Atri-Schuller, Hassan Mohammed Abushukair, Ludimila Cavalcante, Stijn Hentzen, Azhar Saeed, Anwaar Saeed
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer. Current issues in molecular biology 44 (11) (2022)
Hassan Mohammed Abushukair, Sebawe Syaj, Obada E Ababneh, Aref Qarqash, Carolina D Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits Van Rhee, Samer Al Hadidi
First- versus second-generation Bruton tyrosine kinase inhibitors in Waldenström's Macroglobulinemia: A systematic review and meta-analysis. American journal of hematology 97 (7) (2022)
Hassan Mohammed Abushukair, Anwaar Saeed
Assessing the tumor immune microenvironment in gastric carcinoma: a practical approach. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (7) (2022)
Sebawe Syaj, Leen M Al-Kraimeen, Marah Akhdar, Hassan Mohammed Abushukair, Razan Mohty, Samer Al Hadidi
Gender and Early-career Faculty Disparities in Hematology and Oncology Board Review Lecture Series. Blood advances (2022)
Lilit Karapetyan, William Gooding, Aofei Li, Xi Yang, Andrew Knight, Hassan Mohammed Abushukair, Danielle Vargas De Stefano, Cindy Sander, Arivarasan Karunamurthy, Monica Panelli, Walter J Storkus, Ahmad A Tarhini, Joanne M Jeter
Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma. Cancers 14 (20) (2022)